Found 227 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
PHASE1The primary purpose of this study is to determine the safety and efficacy o...
Location
The Affiliated People's Hospital of Ningbo University
Study of Efficacy of BZ019 in Large B-cell Lymphoma
PHASE2This is a single arm,open-label, non-randomized phase 2 study to determine ...
Location
Shanghai Mengchao Cancer Hospital
CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
EARLY_PHASE1The purpose of this study is to assess the safety, tolerability, and effica...
Location
Tongji Hospital, Tongji Medical Collage of Huazhong University of Science & Technology
CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma
PHASE1A prospective study to evaluate the safety and efficacy of CART19 for refra...
Location
the First Affiliated Hospital,School of Medicine, Zhejiang University
A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
PHASE1This study is a single-armed, open-label,multicenter Phase 1/2 study to eva...
Location
Multiple Locations
Relmacabtagene Autoleucel in Hematologic Malignancies
N/ATo evaluate the efficacy and safety of Relmacabtagene Autoleucel in the tre...
Location
Beijing Cancer Hospital
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
PHASE2This trial aims to demonstrate the feasibility of this approach to reliably...
Location
AHN Cancer Institute - West Penn Hospital
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ยฑ ASCT in R/R Aggressive B-Cell Lymphoma
PHASE2This study consists of two sequential treatment phases. In the first phase,...
Location
Institute of Hematology & Blood Diseases Hospital
CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
PHASE1This is a single center, open-label phase 1/2 study to evaluate the safety ...
Location
The First Affiliated Hospital of Soochow University
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
PHASE1This is an open, single-arm, clinical study to evaluate the efficacy and sa...
Location
District One Hospital